nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1B1—Doxorubicin—thyroid cancer	0.0967	0.509	CbGbCtD
Melatonin—CYP2C19—Sorafenib—thyroid cancer	0.0338	0.178	CbGbCtD
Melatonin—CYP1A2—Sorafenib—thyroid cancer	0.0312	0.164	CbGbCtD
Melatonin—CYP2C9—Sorafenib—thyroid cancer	0.0281	0.148	CbGbCtD
Melatonin—EPX—thyroid gland—thyroid cancer	0.0121	0.0702	CbGeAlD
Melatonin—CALR—neck—thyroid cancer	0.0113	0.0655	CbGeAlD
Melatonin—MTNR1B—head—thyroid cancer	0.00912	0.0529	CbGeAlD
Melatonin—ASMT—head—thyroid cancer	0.00889	0.0516	CbGeAlD
Melatonin—CALR—saliva-secreting gland—thyroid cancer	0.00881	0.0511	CbGeAlD
Melatonin—MTNR1A—head—thyroid cancer	0.00721	0.0419	CbGeAlD
Melatonin—CALR—trachea—thyroid cancer	0.00679	0.0394	CbGeAlD
Melatonin—MT3—head—thyroid cancer	0.00604	0.0351	CbGeAlD
Melatonin—IDO1—lymph node—thyroid cancer	0.00569	0.033	CbGeAlD
Melatonin—CALR—thyroid gland—thyroid cancer	0.00537	0.0312	CbGeAlD
Melatonin—NQO2—saliva-secreting gland—thyroid cancer	0.00497	0.0288	CbGeAlD
Melatonin—CALR—head—thyroid cancer	0.00477	0.0277	CbGeAlD
Melatonin—MT3—lymph node—thyroid cancer	0.00423	0.0246	CbGeAlD
Melatonin—NQO2—trachea—thyroid cancer	0.00383	0.0222	CbGeAlD
Melatonin—ESR1—neck—thyroid cancer	0.00348	0.0202	CbGeAlD
Melatonin—CALM2—neck—thyroid cancer	0.00346	0.0201	CbGeAlD
Melatonin—CALM1—neck—thyroid cancer	0.00344	0.02	CbGeAlD
Melatonin—CALM3—saliva-secreting gland—thyroid cancer	0.00344	0.0199	CbGeAlD
Melatonin—CALR—lymph node—thyroid cancer	0.00334	0.0194	CbGeAlD
Melatonin—NQO2—thyroid gland—thyroid cancer	0.00303	0.0176	CbGeAlD
Melatonin—CALM2—saliva-secreting gland—thyroid cancer	0.0027	0.0157	CbGeAlD
Melatonin—NQO2—head—thyroid cancer	0.00269	0.0156	CbGeAlD
Melatonin—CALM1—saliva-secreting gland—thyroid cancer	0.00269	0.0156	CbGeAlD
Melatonin—CALM3—trachea—thyroid cancer	0.00265	0.0154	CbGeAlD
Melatonin—CALM3—thyroid gland—thyroid cancer	0.0021	0.0122	CbGeAlD
Melatonin—CALM2—trachea—thyroid cancer	0.00208	0.0121	CbGeAlD
Melatonin—CALM1—trachea—thyroid cancer	0.00207	0.012	CbGeAlD
Melatonin—MPO—head—thyroid cancer	0.00207	0.012	CbGeAlD
Melatonin—CYP19A1—thyroid gland—thyroid cancer	0.00191	0.0111	CbGeAlD
Melatonin—Mental disorder—Vandetanib—thyroid cancer	0.0019	0.00645	CcSEcCtD
Melatonin—Nasopharyngitis—Sorafenib—thyroid cancer	0.00189	0.00642	CcSEcCtD
Melatonin—Malnutrition—Vandetanib—thyroid cancer	0.00189	0.00641	CcSEcCtD
Melatonin—NQO2—lymph node—thyroid cancer	0.00188	0.0109	CbGeAlD
Melatonin—Gastritis—Sorafenib—thyroid cancer	0.00187	0.00636	CcSEcCtD
Melatonin—Muscle spasms—Vandetanib—thyroid cancer	0.00181	0.00616	CcSEcCtD
Melatonin—CYP1B1—thyroid gland—thyroid cancer	0.00178	0.0103	CbGeAlD
Melatonin—Vision blurred—Vandetanib—thyroid cancer	0.00178	0.00604	CcSEcCtD
Melatonin—Abdominal discomfort—Sorafenib—thyroid cancer	0.00175	0.00595	CcSEcCtD
Melatonin—Psoriasis—Epirubicin—thyroid cancer	0.00171	0.00582	CcSEcCtD
Melatonin—CYP19A1—head—thyroid cancer	0.00169	0.00981	CbGeAlD
Melatonin—Nail disorder—Epirubicin—thyroid cancer	0.00166	0.00564	CcSEcCtD
Melatonin—Loss of consciousness—Vandetanib—thyroid cancer	0.00166	0.00564	CcSEcCtD
Melatonin—ESR1—thyroid gland—thyroid cancer	0.00166	0.00961	CbGeAlD
Melatonin—SLC22A8—head—thyroid cancer	0.00165	0.0096	CbGeAlD
Melatonin—CALM2—thyroid gland—thyroid cancer	0.00165	0.00956	CbGeAlD
Melatonin—CALM1—thyroid gland—thyroid cancer	0.00164	0.00951	CbGeAlD
Melatonin—Hypertension—Vandetanib—thyroid cancer	0.00163	0.00554	CcSEcCtD
Melatonin—Infestation NOS—Sorafenib—thyroid cancer	0.00163	0.00553	CcSEcCtD
Melatonin—Infestation—Sorafenib—thyroid cancer	0.00163	0.00553	CcSEcCtD
Melatonin—Arthralgia—Vandetanib—thyroid cancer	0.00161	0.00546	CcSEcCtD
Melatonin—Chest pain—Vandetanib—thyroid cancer	0.00161	0.00546	CcSEcCtD
Melatonin—Anxiety—Vandetanib—thyroid cancer	0.0016	0.00544	CcSEcCtD
Melatonin—Nabumetone—PTGS2—thyroid cancer	0.0016	1	CrCbGaD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00159	0.00542	CcSEcCtD
Melatonin—CYP1A1—trachea—thyroid cancer	0.00159	0.00924	CbGeAlD
Melatonin—Stomatitis—Sorafenib—thyroid cancer	0.00159	0.00539	CcSEcCtD
Melatonin—Psoriasis—Doxorubicin—thyroid cancer	0.00158	0.00538	CcSEcCtD
Melatonin—CYP1B1—head—thyroid cancer	0.00158	0.00917	CbGeAlD
Melatonin—Dry mouth—Vandetanib—thyroid cancer	0.00157	0.00534	CcSEcCtD
Melatonin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00154	0.00523	CcSEcCtD
Melatonin—Nail disorder—Doxorubicin—thyroid cancer	0.00153	0.00522	CcSEcCtD
Melatonin—Infection—Vandetanib—thyroid cancer	0.00153	0.0052	CcSEcCtD
Melatonin—Nervous system disorder—Vandetanib—thyroid cancer	0.00151	0.00513	CcSEcCtD
Melatonin—Thrombocytopenia—Vandetanib—thyroid cancer	0.00151	0.00512	CcSEcCtD
Melatonin—Skin disorder—Vandetanib—thyroid cancer	0.00149	0.00508	CcSEcCtD
Melatonin—ESR1—head—thyroid cancer	0.00147	0.00853	CbGeAlD
Melatonin—CALM2—head—thyroid cancer	0.00146	0.00848	CbGeAlD
Melatonin—CALM1—head—thyroid cancer	0.00145	0.00844	CbGeAlD
Melatonin—MPO—lymph node—thyroid cancer	0.00145	0.00841	CbGeAlD
Melatonin—Urinary tract disorder—Sorafenib—thyroid cancer	0.00144	0.00491	CcSEcCtD
Melatonin—Connective tissue disorder—Sorafenib—thyroid cancer	0.00144	0.00488	CcSEcCtD
Melatonin—Urethral disorder—Sorafenib—thyroid cancer	0.00143	0.00487	CcSEcCtD
Melatonin—Herpes zoster—Epirubicin—thyroid cancer	0.00143	0.00486	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0014	0.00477	CcSEcCtD
Melatonin—Insomnia—Vandetanib—thyroid cancer	0.00139	0.00473	CcSEcCtD
Melatonin—Paraesthesia—Vandetanib—thyroid cancer	0.00138	0.0047	CcSEcCtD
Melatonin—Cardiac disorder—Sorafenib—thyroid cancer	0.00136	0.00461	CcSEcCtD
Melatonin—Dyspepsia—Vandetanib—thyroid cancer	0.00135	0.00461	CcSEcCtD
Melatonin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00133	0.00452	CcSEcCtD
Melatonin—Glycosuria—Epirubicin—thyroid cancer	0.00133	0.00451	CcSEcCtD
Melatonin—Fatigue—Vandetanib—thyroid cancer	0.00133	0.00451	CcSEcCtD
Melatonin—Angiopathy—Sorafenib—thyroid cancer	0.00133	0.00451	CcSEcCtD
Melatonin—Herpes zoster—Doxorubicin—thyroid cancer	0.00132	0.00449	CcSEcCtD
Melatonin—Immune system disorder—Sorafenib—thyroid cancer	0.00132	0.00449	CcSEcCtD
Melatonin—Pain—Vandetanib—thyroid cancer	0.00132	0.00447	CcSEcCtD
Melatonin—CALM3—lymph node—thyroid cancer	0.0013	0.00756	CbGeAlD
Melatonin—Mental disorder—Sorafenib—thyroid cancer	0.00128	0.00435	CcSEcCtD
Melatonin—CYP1A2—thyroid gland—thyroid cancer	0.00128	0.00741	CbGeAlD
Melatonin—Malnutrition—Sorafenib—thyroid cancer	0.00127	0.00433	CcSEcCtD
Melatonin—Erythema—Sorafenib—thyroid cancer	0.00127	0.00433	CcSEcCtD
Melatonin—CYP1A1—thyroid gland—thyroid cancer	0.00126	0.00731	CbGeAlD
Melatonin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00126	0.00428	CcSEcCtD
Melatonin—Glycosuria—Doxorubicin—thyroid cancer	0.00123	0.00418	CcSEcCtD
Melatonin—Muscle spasms—Sorafenib—thyroid cancer	0.00122	0.00416	CcSEcCtD
Melatonin—Abdominal pain—Vandetanib—thyroid cancer	0.00122	0.00414	CcSEcCtD
Melatonin—CYP19A1—lymph node—thyroid cancer	0.00118	0.00687	CbGeAlD
Melatonin—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00118	0.00402	CcSEcCtD
Melatonin—Hypocalcaemia—Epirubicin—thyroid cancer	0.00117	0.00399	CcSEcCtD
Melatonin—Lacrimation increased—Epirubicin—thyroid cancer	0.00117	0.00397	CcSEcCtD
Melatonin—Angioedema—Sorafenib—thyroid cancer	0.00116	0.00395	CcSEcCtD
Melatonin—Nocturia—Epirubicin—thyroid cancer	0.00116	0.00394	CcSEcCtD
Melatonin—Syncope—Sorafenib—thyroid cancer	0.00114	0.00388	CcSEcCtD
Melatonin—Leukopenia—Sorafenib—thyroid cancer	0.00114	0.00387	CcSEcCtD
Melatonin—Loss of consciousness—Sorafenib—thyroid cancer	0.00112	0.0038	CcSEcCtD
Melatonin—CYP1A1—head—thyroid cancer	0.00112	0.00649	CbGeAlD
Melatonin—CYP1B1—lymph node—thyroid cancer	0.00111	0.00642	CbGeAlD
Melatonin—Asthenia—Vandetanib—thyroid cancer	0.0011	0.00375	CcSEcCtD
Melatonin—Hypertension—Sorafenib—thyroid cancer	0.0011	0.00373	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00109	0.00372	CcSEcCtD
Melatonin—Pruritus—Vandetanib—thyroid cancer	0.00109	0.0037	CcSEcCtD
Melatonin—Neck pain—Epirubicin—thyroid cancer	0.00109	0.0037	CcSEcCtD
Melatonin—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00109	0.0037	CcSEcCtD
Melatonin—Arthralgia—Sorafenib—thyroid cancer	0.00108	0.00368	CcSEcCtD
Melatonin—Lacrimation increased—Doxorubicin—thyroid cancer	0.00108	0.00367	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00108	0.00366	CcSEcCtD
Melatonin—Nocturia—Doxorubicin—thyroid cancer	0.00107	0.00365	CcSEcCtD
Melatonin—Abnormal dreams—Epirubicin—thyroid cancer	0.00106	0.00361	CcSEcCtD
Melatonin—Dry mouth—Sorafenib—thyroid cancer	0.00106	0.0036	CcSEcCtD
Melatonin—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00104	0.00355	CcSEcCtD
Melatonin—Infection—Sorafenib—thyroid cancer	0.00103	0.00351	CcSEcCtD
Melatonin—ESR1—lymph node—thyroid cancer	0.00103	0.00597	CbGeAlD
Melatonin—CALM2—lymph node—thyroid cancer	0.00102	0.00594	CbGeAlD
Melatonin—Shock—Sorafenib—thyroid cancer	0.00102	0.00347	CcSEcCtD
Melatonin—CALM1—lymph node—thyroid cancer	0.00102	0.00591	CbGeAlD
Melatonin—Nervous system disorder—Sorafenib—thyroid cancer	0.00102	0.00346	CcSEcCtD
Melatonin—Dizziness—Vandetanib—thyroid cancer	0.00102	0.00346	CcSEcCtD
Melatonin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00102	0.00346	CcSEcCtD
Melatonin—Skin disorder—Sorafenib—thyroid cancer	0.00101	0.00343	CcSEcCtD
Melatonin—Neck pain—Doxorubicin—thyroid cancer	0.00101	0.00342	CcSEcCtD
Melatonin—Abnormal dreams—Doxorubicin—thyroid cancer	0.000983	0.00334	CcSEcCtD
Melatonin—Vomiting—Vandetanib—thyroid cancer	0.000978	0.00333	CcSEcCtD
Melatonin—Mouth ulceration—Epirubicin—thyroid cancer	0.000972	0.00331	CcSEcCtD
Melatonin—Rash—Vandetanib—thyroid cancer	0.00097	0.0033	CcSEcCtD
Melatonin—Dermatitis—Vandetanib—thyroid cancer	0.000969	0.0033	CcSEcCtD
Melatonin—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000966	0.00329	CcSEcCtD
Melatonin—Headache—Vandetanib—thyroid cancer	0.000964	0.00328	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000946	0.00322	CcSEcCtD
Melatonin—Nausea—Vandetanib—thyroid cancer	0.000914	0.00311	CcSEcCtD
Melatonin—Dyspepsia—Sorafenib—thyroid cancer	0.000914	0.00311	CcSEcCtD
Melatonin—Mouth ulceration—Doxorubicin—thyroid cancer	0.000899	0.00306	CcSEcCtD
Melatonin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000896	0.00305	CcSEcCtD
Melatonin—Fatigue—Sorafenib—thyroid cancer	0.000895	0.00304	CcSEcCtD
Melatonin—Pain—Sorafenib—thyroid cancer	0.000888	0.00302	CcSEcCtD
Melatonin—Eczema—Epirubicin—thyroid cancer	0.000868	0.00295	CcSEcCtD
Melatonin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000849	0.00289	CcSEcCtD
Melatonin—Hot flush—Epirubicin—thyroid cancer	0.000834	0.00284	CcSEcCtD
Melatonin—Menopausal symptoms—Epirubicin—thyroid cancer	0.000827	0.00281	CcSEcCtD
Melatonin—Abdominal pain—Sorafenib—thyroid cancer	0.000821	0.00279	CcSEcCtD
Melatonin—Eczema—Doxorubicin—thyroid cancer	0.000804	0.00273	CcSEcCtD
Melatonin—Lethargy—Epirubicin—thyroid cancer	0.000796	0.00271	CcSEcCtD
Melatonin—Hyponatraemia—Epirubicin—thyroid cancer	0.000784	0.00266	CcSEcCtD
Melatonin—CYP1A1—lymph node—thyroid cancer	0.000783	0.00454	CbGeAlD
Melatonin—Pain in extremity—Epirubicin—thyroid cancer	0.00078	0.00265	CcSEcCtD
Melatonin—Hot flush—Doxorubicin—thyroid cancer	0.000772	0.00263	CcSEcCtD
Melatonin—Migraine—Epirubicin—thyroid cancer	0.000768	0.00261	CcSEcCtD
Melatonin—Affect lability—Epirubicin—thyroid cancer	0.000768	0.00261	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000765	0.0026	CcSEcCtD
Melatonin—Hypersensitivity—Sorafenib—thyroid cancer	0.000765	0.0026	CcSEcCtD
Melatonin—Asthenia—Sorafenib—thyroid cancer	0.000745	0.00253	CcSEcCtD
Melatonin—Mood swings—Epirubicin—thyroid cancer	0.000739	0.00251	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—thyroid cancer	0.000737	0.00251	CcSEcCtD
Melatonin—Pruritus—Sorafenib—thyroid cancer	0.000734	0.0025	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—thyroid cancer	0.000725	0.00247	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—thyroid cancer	0.000722	0.00246	CcSEcCtD
Melatonin—Liver function test abnormal—Epirubicin—thyroid cancer	0.000721	0.00245	CcSEcCtD
Melatonin—Dry skin—Epirubicin—thyroid cancer	0.000715	0.00243	CcSEcCtD
Melatonin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000713	0.00242	CcSEcCtD
Melatonin—Migraine—Doxorubicin—thyroid cancer	0.000711	0.00242	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—thyroid cancer	0.000711	0.00242	CcSEcCtD
Melatonin—Breast disorder—Epirubicin—thyroid cancer	0.000705	0.0024	CcSEcCtD
Melatonin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000698	0.00237	CcSEcCtD
Melatonin—Gastritis—Epirubicin—thyroid cancer	0.000691	0.00235	CcSEcCtD
Melatonin—Dizziness—Sorafenib—thyroid cancer	0.000686	0.00233	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—thyroid cancer	0.000684	0.00233	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000667	0.00227	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—thyroid cancer	0.000662	0.00225	CcSEcCtD
Melatonin—Vomiting—Sorafenib—thyroid cancer	0.00066	0.00224	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00066	0.00224	CcSEcCtD
Melatonin—Angina pectoris—Epirubicin—thyroid cancer	0.000657	0.00223	CcSEcCtD
Melatonin—Rash—Sorafenib—thyroid cancer	0.000654	0.00223	CcSEcCtD
Melatonin—Dermatitis—Sorafenib—thyroid cancer	0.000654	0.00222	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—thyroid cancer	0.000653	0.00222	CcSEcCtD
Melatonin—Headache—Sorafenib—thyroid cancer	0.00065	0.00221	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000646	0.0022	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—thyroid cancer	0.000639	0.00217	CcSEcCtD
Melatonin—Nausea—Sorafenib—thyroid cancer	0.000617	0.0021	CcSEcCtD
Melatonin—Weight increased—Epirubicin—thyroid cancer	0.000614	0.00209	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—thyroid cancer	0.000608	0.00207	CcSEcCtD
Melatonin—Infestation—Epirubicin—thyroid cancer	0.000601	0.00205	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—thyroid cancer	0.000601	0.00205	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—thyroid cancer	0.000586	0.00199	CcSEcCtD
Melatonin—Haematuria—Epirubicin—thyroid cancer	0.000573	0.00195	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000569	0.00193	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—thyroid cancer	0.000568	0.00193	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—thyroid cancer	0.000556	0.00189	CcSEcCtD
Melatonin—Infestation—Doxorubicin—thyroid cancer	0.000556	0.00189	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—thyroid cancer	0.000542	0.00184	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000533	0.00181	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—thyroid cancer	0.000531	0.0018	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000531	0.0018	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—thyroid cancer	0.000529	0.0018	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000526	0.00179	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—thyroid cancer	0.000505	0.00172	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—thyroid cancer	0.000501	0.0017	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000493	0.00168	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000491	0.00167	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—thyroid cancer	0.00049	0.00167	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—thyroid cancer	0.00049	0.00167	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—thyroid cancer	0.000488	0.00166	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—thyroid cancer	0.000473	0.00161	CcSEcCtD
Melatonin—Erythema—Epirubicin—thyroid cancer	0.00047	0.0016	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—thyroid cancer	0.00047	0.0016	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—thyroid cancer	0.000467	0.00159	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000464	0.00158	CcSEcCtD
Melatonin—Flatulence—Epirubicin—thyroid cancer	0.000463	0.00158	CcSEcCtD
Melatonin—Tension—Epirubicin—thyroid cancer	0.000461	0.00157	CcSEcCtD
Melatonin—Nervousness—Epirubicin—thyroid cancer	0.000456	0.00155	CcSEcCtD
Melatonin—Back pain—Epirubicin—thyroid cancer	0.000455	0.00155	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—thyroid cancer	0.000453	0.00154	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—thyroid cancer	0.000452	0.00154	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—thyroid cancer	0.000451	0.00153	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—thyroid cancer	0.000443	0.00151	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—thyroid cancer	0.000438	0.00149	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—thyroid cancer	0.000435	0.00148	CcSEcCtD
Melatonin—Erythema—Doxorubicin—thyroid cancer	0.000435	0.00148	CcSEcCtD
Melatonin—Agitation—Epirubicin—thyroid cancer	0.000432	0.00147	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—thyroid cancer	0.000429	0.00146	CcSEcCtD
Melatonin—Tension—Doxorubicin—thyroid cancer	0.000427	0.00145	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—thyroid cancer	0.000422	0.00144	CcSEcCtD
Melatonin—Vertigo—Epirubicin—thyroid cancer	0.000422	0.00144	CcSEcCtD
Melatonin—Syncope—Epirubicin—thyroid cancer	0.000421	0.00143	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—thyroid cancer	0.000421	0.00143	CcSEcCtD
Melatonin—Back pain—Doxorubicin—thyroid cancer	0.000421	0.00143	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—thyroid cancer	0.000418	0.00142	CcSEcCtD
Melatonin—Palpitations—Epirubicin—thyroid cancer	0.000415	0.00141	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—thyroid cancer	0.000413	0.0014	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—thyroid cancer	0.00041	0.00139	CcSEcCtD
Melatonin—Hypertension—Epirubicin—thyroid cancer	0.000406	0.00138	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—thyroid cancer	0.0004	0.00136	CcSEcCtD
Melatonin—Chest pain—Epirubicin—thyroid cancer	0.0004	0.00136	CcSEcCtD
Melatonin—Agitation—Doxorubicin—thyroid cancer	0.0004	0.00136	CcSEcCtD
Melatonin—Anxiety—Epirubicin—thyroid cancer	0.000399	0.00136	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000397	0.00135	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—thyroid cancer	0.000391	0.00133	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—thyroid cancer	0.000391	0.00133	CcSEcCtD
Melatonin—Syncope—Doxorubicin—thyroid cancer	0.00039	0.00133	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—thyroid cancer	0.000389	0.00132	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—thyroid cancer	0.000384	0.00131	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000382	0.0013	CcSEcCtD
Melatonin—Infection—Epirubicin—thyroid cancer	0.000381	0.0013	CcSEcCtD
Melatonin—Shock—Epirubicin—thyroid cancer	0.000377	0.00128	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—thyroid cancer	0.000376	0.00128	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000376	0.00128	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—thyroid cancer	0.000375	0.00128	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—thyroid cancer	0.000373	0.00127	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—thyroid cancer	0.00037	0.00126	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—thyroid cancer	0.00037	0.00126	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—thyroid cancer	0.000369	0.00125	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000368	0.00125	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—thyroid cancer	0.000362	0.00123	CcSEcCtD
Melatonin—Infection—Doxorubicin—thyroid cancer	0.000353	0.0012	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000349	0.00119	CcSEcCtD
Melatonin—Shock—Doxorubicin—thyroid cancer	0.000349	0.00119	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000348	0.00118	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000348	0.00118	CcSEcCtD
Melatonin—Insomnia—Epirubicin—thyroid cancer	0.000347	0.00118	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—thyroid cancer	0.000345	0.00117	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—thyroid cancer	0.000344	0.00117	CcSEcCtD
Melatonin—Somnolence—Epirubicin—thyroid cancer	0.000341	0.00116	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—thyroid cancer	0.000338	0.00115	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000331	0.00113	CcSEcCtD
Melatonin—Fatigue—Epirubicin—thyroid cancer	0.000331	0.00112	CcSEcCtD
Melatonin—Pain—Epirubicin—thyroid cancer	0.000328	0.00112	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000323	0.0011	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—thyroid cancer	0.000321	0.00109	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—thyroid cancer	0.000319	0.00108	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—thyroid cancer	0.000316	0.00107	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000314	0.00107	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—thyroid cancer	0.000312	0.00106	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000306	0.00104	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—thyroid cancer	0.000306	0.00104	CcSEcCtD
Melatonin—Pain—Doxorubicin—thyroid cancer	0.000304	0.00103	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—thyroid cancer	0.000303	0.00103	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00029	0.000987	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—thyroid cancer	0.000283	0.000961	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—thyroid cancer	0.000281	0.000954	CcSEcCtD
Melatonin—Asthenia—Epirubicin—thyroid cancer	0.000275	0.000936	CcSEcCtD
Melatonin—Pruritus—Epirubicin—thyroid cancer	0.000271	0.000923	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000261	0.000889	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—thyroid cancer	0.000255	0.000866	CcSEcCtD
Melatonin—Dizziness—Epirubicin—thyroid cancer	0.000254	0.000863	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—thyroid cancer	0.000251	0.000854	CcSEcCtD
Melatonin—Vomiting—Epirubicin—thyroid cancer	0.000244	0.000829	CcSEcCtD
Melatonin—Rash—Epirubicin—thyroid cancer	0.000242	0.000823	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—thyroid cancer	0.000242	0.000822	CcSEcCtD
Melatonin—Headache—Epirubicin—thyroid cancer	0.00024	0.000817	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—thyroid cancer	0.000235	0.000798	CcSEcCtD
Melatonin—Nausea—Epirubicin—thyroid cancer	0.000228	0.000775	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—thyroid cancer	0.000226	0.000767	CcSEcCtD
Melatonin—Rash—Doxorubicin—thyroid cancer	0.000224	0.000761	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—thyroid cancer	0.000224	0.00076	CcSEcCtD
Melatonin—Headache—Doxorubicin—thyroid cancer	0.000222	0.000756	CcSEcCtD
Melatonin—Nausea—Doxorubicin—thyroid cancer	0.000211	0.000717	CcSEcCtD
Melatonin—CALM3—Metabolism—SLC5A5—thyroid cancer	3.54e-05	0.000103	CbGpPWpGaD
Melatonin—CALM3—RNF mutants show enhanced WNT signaling and proliferation—AKT1—thyroid cancer	3.47e-05	0.000102	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—PPARG—thyroid cancer	3.46e-05	0.000101	CbGpPWpGaD
Melatonin—CALM2—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	3.43e-05	0.0001	CbGpPWpGaD
Melatonin—CALM1—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	3.43e-05	0.0001	CbGpPWpGaD
Melatonin—CALM2—Metabolism—SLC5A5—thyroid cancer	3.42e-05	0.0001	CbGpPWpGaD
Melatonin—CALM1—Metabolism—SLC5A5—thyroid cancer	3.42e-05	0.0001	CbGpPWpGaD
Melatonin—CALM2—RNF mutants show enhanced WNT signaling and proliferation—AKT1—thyroid cancer	3.36e-05	9.82e-05	CbGpPWpGaD
Melatonin—CALM1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—thyroid cancer	3.36e-05	9.82e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTCH1—thyroid cancer	3.36e-05	9.82e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—SLC5A5—thyroid cancer	3.36e-05	9.81e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—TPR—thyroid cancer	3.34e-05	9.78e-05	CbGpPWpGaD
Melatonin—CALM3—Neuronal System—HRAS—thyroid cancer	3.34e-05	9.75e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRG1—thyroid cancer	3.32e-05	9.71e-05	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—AKT1—thyroid cancer	3.3e-05	9.66e-05	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—AKT1—thyroid cancer	3.3e-05	9.66e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	3.29e-05	9.62e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.27e-05	9.56e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—HRAS—thyroid cancer	3.27e-05	9.56e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTCH1—thyroid cancer	3.25e-05	9.5e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTCH1—thyroid cancer	3.25e-05	9.5e-05	CbGpPWpGaD
Melatonin—CALM2—Neuronal System—HRAS—thyroid cancer	3.23e-05	9.43e-05	CbGpPWpGaD
Melatonin—CALM1—Neuronal System—HRAS—thyroid cancer	3.23e-05	9.43e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by WNT in cancer—AKT1—thyroid cancer	3.23e-05	9.43e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRG1—thyroid cancer	3.21e-05	9.4e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRG1—thyroid cancer	3.21e-05	9.4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—HRAS—thyroid cancer	3.16e-05	9.25e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—HRAS—thyroid cancer	3.16e-05	9.25e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.14e-05	9.19e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by WNT in cancer—AKT1—thyroid cancer	3.12e-05	9.12e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by WNT in cancer—AKT1—thyroid cancer	3.12e-05	9.12e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRG1—thyroid cancer	3.08e-05	9e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SST—thyroid cancer	3.07e-05	8.98e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRG1—thyroid cancer	3.07e-05	8.97e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PPARG—thyroid cancer	3e-05	8.77e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.98e-05	8.72e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SST—thyroid cancer	2.97e-05	8.69e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SST—thyroid cancer	2.97e-05	8.69e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—RXRA—thyroid cancer	2.97e-05	8.68e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NRG1—thyroid cancer	2.97e-05	8.67e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NRG1—thyroid cancer	2.97e-05	8.67e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CALCA—thyroid cancer	2.96e-05	8.64e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PPARG—thyroid cancer	2.89e-05	8.45e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—AKT1—thyroid cancer	2.89e-05	8.44e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—RXRA—thyroid cancer	2.87e-05	8.4e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—RXRA—thyroid cancer	2.87e-05	8.4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CALCA—thyroid cancer	2.86e-05	8.36e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CALCA—thyroid cancer	2.86e-05	8.36e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—TPR—thyroid cancer	2.86e-05	8.35e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—PTEN—thyroid cancer	2.86e-05	8.35e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—NRAS—thyroid cancer	2.83e-05	8.28e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—RXRA—thyroid cancer	2.82e-05	8.24e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.81e-05	8.22e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—AKT1—thyroid cancer	2.79e-05	8.16e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—AKT1—thyroid cancer	2.79e-05	8.16e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—PTEN—thyroid cancer	2.76e-05	8.08e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—PTEN—thyroid cancer	2.76e-05	8.08e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TERT—thyroid cancer	2.76e-05	8.08e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—TERT—thyroid cancer	2.76e-05	8.05e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.75e-05	8.03e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—PTEN—thyroid cancer	2.74e-05	8.02e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.74e-05	8.01e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—NRAS—thyroid cancer	2.74e-05	8.01e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—NRAS—thyroid cancer	2.74e-05	8.01e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDK1—thyroid cancer	2.68e-05	7.82e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—TERT—thyroid cancer	2.67e-05	7.79e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—TERT—thyroid cancer	2.67e-05	7.79e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by Wnt—AKT1—thyroid cancer	2.66e-05	7.77e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—PTEN—thyroid cancer	2.65e-05	7.76e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—PTEN—thyroid cancer	2.65e-05	7.76e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HIF1A—thyroid cancer	2.64e-05	7.72e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HIF1A—thyroid cancer	2.63e-05	7.7e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDK1—thyroid cancer	2.59e-05	7.57e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDK1—thyroid cancer	2.59e-05	7.57e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.57e-05	7.52e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by Wnt—AKT1—thyroid cancer	2.57e-05	7.52e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by Wnt—AKT1—thyroid cancer	2.57e-05	7.52e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—NRAS—thyroid cancer	2.55e-05	7.45e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.55e-05	7.45e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HIF1A—thyroid cancer	2.55e-05	7.45e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HIF1A—thyroid cancer	2.55e-05	7.45e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.5e-05	7.32e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—NRAS—thyroid cancer	2.47e-05	7.21e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—NRAS—thyroid cancer	2.47e-05	7.21e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—NRAS—thyroid cancer	2.45e-05	7.16e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—KRAS—thyroid cancer	2.44e-05	7.12e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—NRAS—thyroid cancer	2.37e-05	6.92e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—NRAS—thyroid cancer	2.37e-05	6.92e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTGS2—thyroid cancer	2.36e-05	6.9e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—KRAS—thyroid cancer	2.36e-05	6.89e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—KRAS—thyroid cancer	2.36e-05	6.89e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.35e-05	6.86e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—RXRA—thyroid cancer	2.31e-05	6.74e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTGS2—thyroid cancer	2.27e-05	6.65e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.24e-05	6.56e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—KRAS—thyroid cancer	2.19e-05	6.41e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—BRAF—thyroid cancer	2.19e-05	6.4e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—BRAF—thyroid cancer	2.18e-05	6.38e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—thyroid cancer	2.17e-05	6.33e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRG1—thyroid cancer	2.15e-05	6.28e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.14e-05	6.25e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—KRAS—thyroid cancer	2.12e-05	6.2e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—KRAS—thyroid cancer	2.12e-05	6.2e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—BRAF—thyroid cancer	2.11e-05	6.17e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—BRAF—thyroid cancer	2.11e-05	6.17e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—KRAS—thyroid cancer	2.11e-05	6.16e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—RXRA—thyroid cancer	2.1e-05	6.15e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—thyroid cancer	2.1e-05	6.13e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—thyroid cancer	2.1e-05	6.13e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRG1—thyroid cancer	2.08e-05	6.07e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRG1—thyroid cancer	2.08e-05	6.07e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—HRAS—thyroid cancer	2.07e-05	6.06e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTEN—thyroid cancer	2.06e-05	6.02e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.05e-05	5.98e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KRAS—thyroid cancer	2.04e-05	5.96e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KRAS—thyroid cancer	2.04e-05	5.96e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.01e-05	5.86e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—HRAS—thyroid cancer	2e-05	5.86e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—HRAS—thyroid cancer	2e-05	5.86e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTEN—thyroid cancer	1.98e-05	5.8e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TERT—thyroid cancer	1.93e-05	5.64e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PPARG—thyroid cancer	1.88e-05	5.48e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TERT—thyroid cancer	1.87e-05	5.45e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TERT—thyroid cancer	1.87e-05	5.45e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—HRAS—thyroid cancer	1.87e-05	5.45e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HIF1A—thyroid cancer	1.85e-05	5.39e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—AKT1—thyroid cancer	1.83e-05	5.35e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PPARG—thyroid cancer	1.81e-05	5.3e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PPARG—thyroid cancer	1.81e-05	5.3e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—HRAS—thyroid cancer	1.8e-05	5.27e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—HRAS—thyroid cancer	1.8e-05	5.27e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—RXRA—thyroid cancer	1.8e-05	5.25e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HRAS—thyroid cancer	1.79e-05	5.24e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HIF1A—thyroid cancer	1.78e-05	5.22e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HIF1A—thyroid cancer	1.78e-05	5.22e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PPARG—thyroid cancer	1.78e-05	5.2e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—AKT1—thyroid cancer	1.77e-05	5.17e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—AKT1—thyroid cancer	1.77e-05	5.17e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTGS2—thyroid cancer	1.76e-05	5.15e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.75e-05	5.11e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HRAS—thyroid cancer	1.73e-05	5.06e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HRAS—thyroid cancer	1.73e-05	5.06e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—thyroid cancer	1.7e-05	4.98e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—thyroid cancer	1.7e-05	4.98e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PTEN—thyroid cancer	1.66e-05	4.87e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—AKT1—thyroid cancer	1.65e-05	4.81e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—NRAS—thyroid cancer	1.63e-05	4.75e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PTEN—thyroid cancer	1.61e-05	4.71e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PTEN—thyroid cancer	1.61e-05	4.71e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCND1—thyroid cancer	1.6e-05	4.67e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—AKT1—thyroid cancer	1.59e-05	4.66e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—AKT1—thyroid cancer	1.59e-05	4.66e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—AKT1—thyroid cancer	1.58e-05	4.62e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—NRAS—thyroid cancer	1.57e-05	4.6e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—NRAS—thyroid cancer	1.57e-05	4.6e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PTEN—thyroid cancer	1.54e-05	4.51e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTEN—thyroid cancer	1.54e-05	4.49e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—AKT1—thyroid cancer	1.53e-05	4.47e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—AKT1—thyroid cancer	1.53e-05	4.47e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—BRAF—thyroid cancer	1.53e-05	4.47e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—thyroid cancer	1.49e-05	4.35e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—thyroid cancer	1.49e-05	4.35e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRAS—thyroid cancer	1.49e-05	4.34e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—thyroid cancer	1.48e-05	4.32e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—thyroid cancer	1.48e-05	4.32e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—thyroid cancer	1.48e-05	4.31e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPARG—thyroid cancer	1.46e-05	4.26e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—thyroid cancer	1.44e-05	4.2e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—thyroid cancer	1.44e-05	4.2e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—thyroid cancer	1.43e-05	4.17e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—thyroid cancer	1.43e-05	4.17e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—thyroid cancer	1.4e-05	4.09e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—thyroid cancer	1.4e-05	4.09e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—thyroid cancer	1.38e-05	4.02e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—thyroid cancer	1.37e-05	4.01e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—thyroid cancer	1.37e-05	3.99e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—thyroid cancer	1.35e-05	3.96e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—thyroid cancer	1.35e-05	3.96e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARG—thyroid cancer	1.33e-05	3.88e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—thyroid cancer	1.33e-05	3.88e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—thyroid cancer	1.33e-05	3.88e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—thyroid cancer	1.29e-05	3.76e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—thyroid cancer	1.28e-05	3.74e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—thyroid cancer	1.25e-05	3.64e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—thyroid cancer	1.25e-05	3.64e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—thyroid cancer	1.24e-05	3.61e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—thyroid cancer	1.24e-05	3.61e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—thyroid cancer	1.22e-05	3.57e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—thyroid cancer	1.19e-05	3.48e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—thyroid cancer	1.19e-05	3.47e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—thyroid cancer	1.18e-05	3.46e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—thyroid cancer	1.18e-05	3.45e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—thyroid cancer	1.15e-05	3.36e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—thyroid cancer	1.15e-05	3.36e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.15e-05	3.35e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—thyroid cancer	1.14e-05	3.34e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—thyroid cancer	1.14e-05	3.34e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—thyroid cancer	1.14e-05	3.34e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARG—thyroid cancer	1.14e-05	3.32e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—thyroid cancer	1.12e-05	3.26e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—thyroid cancer	1.09e-05	3.18e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—thyroid cancer	1.08e-05	3.15e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—thyroid cancer	1.08e-05	3.15e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—thyroid cancer	1.08e-05	3.15e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—thyroid cancer	1.05e-05	3.07e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—thyroid cancer	1.05e-05	3.07e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—thyroid cancer	1.05e-05	3.07e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—thyroid cancer	1.05e-05	3.07e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.04e-05	3.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—thyroid cancer	1.04e-05	3.04e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—thyroid cancer	1.04e-05	3.04e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—thyroid cancer	1.02e-05	2.97e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—thyroid cancer	1.02e-05	2.97e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—thyroid cancer	1.01e-05	2.94e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—thyroid cancer	1e-05	2.93e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—thyroid cancer	9.99e-06	2.92e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—thyroid cancer	9.7e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—thyroid cancer	9.7e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—thyroid cancer	9.6e-06	2.81e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—thyroid cancer	9.59e-06	2.8e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—thyroid cancer	9.29e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—thyroid cancer	9.29e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—thyroid cancer	9.28e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—thyroid cancer	9.28e-06	2.71e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—thyroid cancer	9.11e-06	2.66e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—thyroid cancer	8.93e-06	2.61e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—thyroid cancer	8.88e-06	2.6e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—thyroid cancer	8.86e-06	2.59e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—thyroid cancer	8.57e-06	2.5e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—thyroid cancer	8.57e-06	2.5e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—thyroid cancer	8.26e-06	2.42e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—thyroid cancer	7.99e-06	2.34e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—thyroid cancer	7.99e-06	2.34e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—thyroid cancer	7.79e-06	2.28e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—thyroid cancer	7.42e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—thyroid cancer	7.35e-06	2.15e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—thyroid cancer	7.18e-06	2.1e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—thyroid cancer	7.18e-06	2.1e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—thyroid cancer	7.11e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—thyroid cancer	7.11e-06	2.08e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—thyroid cancer	7.04e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—thyroid cancer	7.02e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—thyroid cancer	6.8e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—thyroid cancer	6.8e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—thyroid cancer	6.2e-06	1.81e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—thyroid cancer	6e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—thyroid cancer	6e-06	1.75e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—thyroid cancer	5.76e-06	1.68e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—thyroid cancer	5.25e-06	1.53e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—thyroid cancer	4.49e-06	1.31e-05	CbGpPWpGaD
